Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance

Molecular and Cellular Biochemistry

Volumn 344, Issue 1-2, 2010, Pages 23-31

  Lei, Yu ^a   Geng, Zhang ^a   Guo Jun, Wu ^a   He, Wang ^a   Jian Lin, Yuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Inhibitor of apoptosis; Prognosis; Radiosensitivity; Renal cell cancer; RNA interference; Survivin

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA; SURVIVIN;

ADULT; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CARCINOMA CELL; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISTANT METASTASIS; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIOSENSITIVITY;

BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; FEMALE; HUMANS; IN SITU NICK-END LABELING; KIDNEY NEOPLASMS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PROGNOSIS; RADIATION TOLERANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 78449284621     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0525-3     Document Type: Article

References (33)

1. DM Parkin F Bray J Ferlay, et al. 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 15761078
2. AC Buzaid MB Todd 1989 Therapeutic options in renal cell carcinoma Semin Oncol 16 Suppl 6 12 16 1:STN:280:DyaL1M7ks1Wkug%3D%3D 2465574
3. DC Altieri 2003 Survivin, versatilemodulation of cell division and apoptosis in cancer Oncogene 22 8581 8589 1:CAS:528:DC%2BD3sXptFOmtbY%3D 10.1038/sj.onc.1207113 14634620
4. GY Chau AF Lee SH Tsay, et al. 2007 Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma Histopathology 51 204 218 10.1111/j.1365-2559.2007.02738.x 17559540
5. WC Chen Q Liu JX Fu, et al. 2004 Expression of survivin and its significance in colorectal cancer World J Gastroenterol 10 2886 2889 1:CAS:528:DC%2BD2cXovVWntLY%3D 15334693
6. M Falleni C Pellegrini A Marchetti, et al. 2003 Survivin gene expression in early-stage non-small cell lung cancer J Pathol 200 620 626 1:CAS:528:DC%2BD3sXntl2nurk%3D 10.1002/path.1388 12898598
7. AI Sarela CS Verbeke J Ramsdale, et al. 2002 Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma Br J Cancer 86 886 892 1:CAS:528:DC%2BD38XjsVyqtrw%3D 10.1038/sj.bjc.6600133 11953819
8. E Osaka T Suzuki S Osaka, et al. 2006 Survivin as a prognostic factor for osteosarcoma patients Acta Histochem Cytochem 39 95 100 1:CAS:528: DC%2BD28XosVKis7g%3D 10.1267/ahc.06005 17327929
9. K Asanuma D Kobayashi D Furuya, et al. 2002 A role for survivin in radioresistance of pancreatic cancer cells Jpn J Cancer Res 93 1057 1062 1:CAS:528:DC%2BD38XptlejsLg%3D 12359060
10. F Rödel J Hoffmann L Distel, et al. 2005 Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer Cancer Res 65 4881 4887 10.1158/0008-5472.CAN-04-3028 15930309
11. RJ Motzer NH Bander DM Nanus 1996 Renal-cell carcinoma N Engl J Med 335 865 875 1:STN:280:DyaK28zlslajtA%3D%3D 10.1056/NEJM199609193351207 8778606
12. EC La Casse S Baird RG Korneluk, et al. 1998 The inhibitors of apoptosis (IAPs) and their emerging role in cancer Oncogene 17 3247 3259 10.1038/sj.onc.1202569
13. QL Deveraux R Takahashi GS Salvesen, et al. 1997 X-linked IAP is a direct inhibitor of cell death proteases Nature 388 300 304 1:STN:280: DyaK2szntl2muw%3D%3D 10.1038/40901 9230442
14. QL Deveraux JC Reed 1999 IAP family proteins: suppressors of apoptosis Genes Dev 13 239 252 1:CAS:528:DyaK1MXht1KgsL0%3D 10.1101/gad.13.3.239 9990849
15. G Ambrosini C Adida DC Altieri 1997 A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat Med 3 917 921 1:CAS:528:DyaK2sXltVylt7w%3D 10.1038/nm0897-917 9256286
16. ME Johnson EW Howerth 2004 Survivin: a bifunctional inhibitor of apoptosis protein Vet Pathol 41 599 607 1:CAS:528:DC%2BD2cXhtFahtr3L 10.1354/vp.41-6-599 15557069
17. N Nouraee SJ Mowla A Ozhand, et al. 2009 Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker Urol J 6 101 108 19472128
18. AC Fields G Cotsonis D Sexton, et al. 2004 Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome Mod Pathol 17 1378 1385 1:CAS:528:DC%2BD2cXhtVWltL3K 10.1038/modpathol.3800203 15195112
19. C Cohen CM Lohmann G Cotsonis, et al. 2003 Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis Mod Pathol 16 574 583 10.1097/01.MP.0000073868.31297.B0 12808063
20. KY Song CK Jung WS Park, et al. 2009 Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma Jpn J Clin Oncol 39 290 296 10.1093/jjco/hyp020 19336448
21. A Troeger M Siepermann G Escherich, et al. 2007 Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia Haematologica 92 1043 1050 1:CAS:528:DC%2BD2sXhtFKrsrbK 10.3324/haematol.10675 17640858
22. C Adida C Recher E Raffoux, et al. 2000 Expression and prognostic significance of survivin in de novo acute myeloid leukaemia Br J Haematol 111 196 203 1:CAS:528:DC%2BD3cXosFSnsr8%3D 10.1046/j.1365-2141.2000.02328.x 11091201
23. JJ Virrey S Guan W Li, et al. 2008 Increased survivin expression confers chemoresistance to tumor-associated endothelial cells Am J Pathol 173 575 585 1:CAS:528:DC%2BD1cXhtVegtbjM 10.2353/ajpath.2008.071079 18599610
24. QZ Yuan CT Wang YQ Mao, et al. 2010 Enhanced tumor radiosensitivity by a survivin dominant-negative mutant Oncol Rep 23 97 103 19956869
25. N Zaffaroni MG Daidone 2002 Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions Drug Resist Updat 5 65 72 1:CAS:528:DC%2BD38XosFKjurg%3D 10.1016/S1368-7646(02)00049- 3 12135582
26. BM Ryan N O'Donovan MJ Duffy 2009 Survivin: a new target for anti-cancer therapy Cancer Treat Rev 35 553 562 1:CAS:528:DC%2BD1MXhtlCgt7zM 10.1016/j.ctrv.2009.05.003 19559538
27. K Kami R Doi M Koizumi, et al. 2005 Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells Surgery 138 299 305 10.1016/j.surg.2005.05.009 16153440
28. J Shen J Liu Y Long, et al. 2009 Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity Acta Biochim Biophys Sin 41 223 230 1:CAS:528: DC%2BD1MXivFeqsLY%3D 10.1093/abbs/gmp005 19280061
29. A Sato K Ito T Asano, et al. 2007 Synergistic effect of survivin-specific small interfering RNA and topotecan in renal cancer cells: topotecan enhances liposome-mediated transfection by increasing cellular uptake Int J Oncol 30 670 695
30. X Song JB Wang DL Yin, et al. 2009 Down-regulation of lung resistance related protein by RNA interference targeting survivin induces the reversal of chemoresistances in hepatocellular carcinoma Chin Med J 122 2636 2642 1:CAS:528:DC%2BD1MXhsFenu7nJ 19951584
31. S Fulda KM Debatin 2004 Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol Cancer Res 64 337 346 1:CAS:528:DC%2BD2cXkslyrsA%3D%3D 10.1158/0008-5472.CAN-03-1656 14729643
32. R Zamparese G Pannone A Santoro, et al. 2008 Survivin expression in renal cell carcinoma Cancer Invest 26 929 935 1:CAS:528:DC%2BD1cXhsVCms77F 10.1080/07357900802017553 19034775
33. SS Byun WG Yeo SE Lee, et al. 2007 Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome Urology 69 1 34 37 10.1016/j.urology.2006.09.024 17270609